Accent Microcell (NSE:ACCENTMIC) Debt-to-EBITDA : 0.31 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Accent Microcell Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Accent Microcell's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹113 Mil. Accent Microcell's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹15 Mil. Accent Microcell's annualized EBITDA for the quarter that ended in Mar. 2024 was ₹420 Mil. Accent Microcell's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.30.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Accent Microcell's Debt-to-EBITDA or its related term are showing as below:

NSE:ACCENTMIC' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.31 Med: 1.37 Max: 2.46
Current: 0.31

During the past 4 years, the highest Debt-to-EBITDA Ratio of Accent Microcell was 2.46. The lowest was 0.31. And the median was 1.37.

NSE:ACCENTMIC's Debt-to-EBITDA is ranked better than
77.71% of 673 companies
in the Drug Manufacturers industry
Industry Median: 1.68 vs NSE:ACCENTMIC: 0.31

Accent Microcell Debt-to-EBITDA Historical Data

The historical data trend for Accent Microcell's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accent Microcell Debt-to-EBITDA Chart

Accent Microcell Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Debt-to-EBITDA

2.46

1.66

1.08

0.31

Accent Microcell Semi-Annual Data
	Mar21	Mar22	Mar23	Mar24
Debt-to-EBITDA	2.46	1.66	1.08	0.31

Competitive Comparison of Accent Microcell's Debt-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accent Microcell's Debt-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Accent Microcell's Debt-to-EBITDA falls into.

Save Embed

;

Save Embed

;

Accent Microcell Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Accent Microcell's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(112.928	+	14.981)	/	419.511
	=	0.30

Accent Microcell's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(112.928	+	14.981)	/	419.511
	=	0.30

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is one times the quarterly (Mar. 2024) EBITDA data.

Accent Microcell (NSE:ACCENTMIC) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Accent Microcell Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Accent Microcell's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Accent Microcell Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accent Microcell Ltd (NSE:ACCENTMIC) » Definitions » Debt-to-EBITDA

Traded in Other Exchanges

N/A

Address

Shyamal Cross Roads, Anandnagar Road, 314, Shangrilla Arcade, Satellite, Ahmedabad, GJ, IND, 380015

Website

https://www.accentmicrocell.com

Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit) which generates maximum revenue, Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.

Accent Microcell Headlines

No Headlines